Insider Trading: CytRx Corp (CYTR.W)

CYTR.W on CBOE When Trading NASDAQ Global Select Market

2.42USD
13 May 2013
Price Change (% chg)

$0.02 (+0.83%)
Prev Close
$2.40
Open
$2.40
Day's High
$2.42
Day's Low
$2.40
Volume
200
Avg. Vol
84
52-wk High
$5.39
52-wk Low
$1.62

Search Stocks
LEVITT DANIEL J
Trading Date Type Shares Traded Price Shares Held
30 Dec 2012 Buy 100,000 $0.00 114,286
21 Feb 2012 Buy 100,000 $0.29 100,000
Previous Page 1 of 1

Institutional Holders

% Shares Owned: 11.05%
# of Holders: 38
Total Shares Held: 3,371,420
3 Mo. Net Change: -226,320
# New Positions: 8
# Closed Positions: 4
# Increased Positions: 16
# Reduced Positions: 7
# Net Buyers: 9

Officers & Directors

Name Age Since Current Position

Max Link

 72 2002 Independent Chairman of the Board

Steven Kriegsman

 71 2002 President, Chief Executive Officer, Director

Marvin Selter

 85 2004 Independent Vice Chairman of the Board

John Caloz

 61 2009 Chief Financial Officer

Daniel Levitt

 65 2013 Executive Vice President, Chief Medical Officer

Douglas Wieland

 53 2008 Senior Vice President - Drug Development

Benjamin Levin

 36 2004 Vice President - Legal Affairs, General Counsel, Corporate Secretary

David Haen

 34 2007 Vice President - Business Development

Louis Ignarro

 71 2002 Independent Director

Joseph Rubinfeld

 80 2002 Independent Director

Richard Wennekamp

 70 2003 Independent Director

Thomas Wagner

 IR Contact
Search Stocks